ÂÜÀòÂÒÂ×

Jean-Philippe Meyer has extensive work experience in various roles within the pharmaceutical and research fields. Jean-Philippe started their career as a Post-doctoral fellow at The University of Arizona, where they focused on synthesizing peptidic analogs. Jean-Philippe then worked as a Researcher at the Torrey Pines Institute for Molecular Studies before joining Bristol-Myers Squibb as a Research Investigator. Jean-Philippe later became a Group Leader of Analytical Chemistry and Natural Substances at Entomed. Jean-Philippe then joined Evolva Group as Director of CMC & Analytics, where they led compound development and regulatory analyses. Jean-Philippe was later promoted to Vice President of Regulatory Affairs at Evolva Group. Throughout their career, Jean-Philippe has demonstrated expertise in synthetic route scouting, development, and scale-up, as well as compliance with GMP procedures and ICH guidelines.

Jean-Philippe Meyer obtained their Baccalauréat from Lycée Kléber, Strasbourg (France) in 1982. Jean-Philippe then attended Ecole Nationale Supérieure de Chimie de Strasbourg (France) from 1984 to 1987, majoring in Chemistry. Jean-Philippe completed their DEA in Pharmaceutics and Drug Design at University René Descartes, Paris, France in 1988. Jean-Philippe continued their education at the University of Pharmacy of Strasbourg (France) from 1988 to 1992, where they obtained a Doctor of Philosophy (Ph.D.) in Chemistry with a specialization in Analytics.